Key result
The myocardial microcirculation plays a critical role in post-ischemic injury and should be a principal target of future therapies to improve clinical outcomes in patients with evolving myocardial infarction.
Why the study?
Should the cardiac microcirculation be a principal target to improve clinical outcomes in patients with evolving myocardial infarction?
Should the cardiac microcirculation be a principal target to improve clinical outcomes in patients with evolving myocardial infarction?
This review highlights the critical role of the myocardial microcirculation in acute myocardial infarction and advocates for it as a key therapeutic target.
No takes yet. Share an insight, caveat, or question.
Microcirculatory protection merits investigation in evolving MI; leaves open whether it should become a principal clinical target.
John G. Kingma (2013) conducted a review in Acute myocardial infarction. Targeting myocardial microcirculation was evaluated. The myocardial microcirculation plays a critical role in post-ischemic injury and should be a principal target of future therapies to improve clinical outcomes in patients with evolving myocardial infarction.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: